These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33838651)

  • 1. PET/MR imaging for the evaluation of cervical cancer during pregnancy.
    Ishiguro T; Nishikawa N; Ishii S; Yoshihara K; Haino K; Yamaguchi M; Adachi S; Watanabe T; Soeda S; Enomoto T
    BMC Pregnancy Childbirth; 2021 Apr; 21(1):288. PubMed ID: 33838651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
    Driscoll DO; Halpenny D; Johnston C; Sheehy N; Keogan M
    Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer.
    Park W; Park YJ; Huh SJ; Kim BG; Bae DS; Lee J; Kim BH; Choi JY; Ahn YC; Lim DH
    Jpn J Clin Oncol; 2005 May; 35(5):260-4. PubMed ID: 15886267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of parametrial infiltration in cervical cancer with voxel-based segmentation of integrated
    Wang T; Sun H; Han F; Sun W; Chen Z
    Eur J Radiol; 2019 Sep; 118():147-152. PubMed ID: 31439234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative PET/CT FDG standardized uptake value of pelvic lymph nodes as a significant prognostic factor in patients with uterine cervical cancer.
    Chung HH; Cheon GJ; Kang KW; Kim JW; Park NH; Song YS
    Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):674-81. PubMed ID: 24233005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study.
    Pinker K; Andrzejewski P; Baltzer P; Polanec SH; Sturdza A; Georg D; Helbich TH; Karanikas G; Grimm C; Polterauer S; Poetter R; Wadsak W; Mitterhauser M; Georg P
    PLoS One; 2016; 11(5):e0155333. PubMed ID: 27167829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of
    Sarabhai T; Schaarschmidt BM; Wetter A; Kirchner J; Aktas B; Forsting M; Ruhlmann V; Herrmann K; Umutlu L; Grueneisen J
    Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):67-76. PubMed ID: 28840302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic efficiency of whole-body
    Steiner A; Narva S; Rinta-Kiikka I; Hietanen S; Hynninen J; Virtanen J
    Cancer Imaging; 2021 Jan; 21(1):16. PubMed ID: 33482909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer.
    Sala E; Micco M; Burger IA; Yakar D; Kollmeier MA; Goldman DA; Gonen M; Park KJ; Abu-Rustum NR; Hricak H; Vargas HA
    Int J Gynecol Cancer; 2015 Oct; 25(8):1461-7. PubMed ID: 26397068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients.
    Kim SK; Choi HJ; Park SY; Lee HY; Seo SS; Yoo CW; Jung DC; Kang S; Cho KS
    Eur J Cancer; 2009 Aug; 45(12):2103-9. PubMed ID: 19403303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary epithelioid trophoblastic tumor with a synchronous breast carcinoma detected only with FDG-PET/CT Scan.
    Kara T; Ozcan Kara P; Baba F; Celik C; Kara Gedik G
    Rev Esp Med Nucl; 2011; 30(6):368-71. PubMed ID: 21440960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
    Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E
    Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with
    Lin AJ; Wright JD; Dehdashti F; Siegel BA; Markovina S; Schwarz J; Thaker PH; Mutch DG; Powell MA; Grigsby PW
    Int J Gynecol Cancer; 2019 Nov; 29(9):1351-1354. PubMed ID: 31473660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of whole-body FDG-PET in preoperative assessment of tumor staging in oral cancers.
    Nakasone Y; Inoue T; Oriuchi N; Takeuchi K; Negishi A; Endo K; Mogi K
    Ann Nucl Med; 2001 Dec; 15(6):505-12. PubMed ID: 11831398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of 18F-FDG-PET/MR for preoperative breast cancer staging.
    Botsikas D; Kalovidouri A; Becker M; Copercini M; Djema DA; Bodmer A; Monnier S; Becker CD; Montet X; Delattre BM; Ratib O; Garibotto V; Tabouret-Viaud C
    Eur Radiol; 2016 Jul; 26(7):2297-307. PubMed ID: 26477029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative [18F]FDG PET/CT maximum standardized uptake value predicts recurrence of uterine cervical cancer.
    Chung HH; Nam BH; Kim JW; Kang KW; Park NH; Song YS; Chung JK; Kang SB
    Eur J Nucl Med Mol Imaging; 2010 Aug; 37(8):1467-73. PubMed ID: 20352210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
    Kim HJ; Cho A; Yun M; Kim YT; Kang WJ
    Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (18)F-FDG PET/CT can correct the clinical stages and predict pathological parameters before operation in cervical cancer.
    Yang Z; Xu W; Ma Y; Liu K; Li Y; Wang D
    Eur J Radiol; 2016 May; 85(5):877-84. PubMed ID: 27130046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of FDG PET-CT on the management of patients with locally advanced cervical carcinoma.
    Fleming S; Cooper RA; Swift SE; Thygesen HH; Chowdhury FU; Scarsbrook AF; Patel CN
    Clin Radiol; 2014 Dec; 69(12):1235-43. PubMed ID: 25439186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer.
    Kidd EA; Siegel BA; Dehdashti F; Grigsby PW
    Cancer; 2010 Mar; 116(6):1469-75. PubMed ID: 20108309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.